March 5 (Reuters) - Astrazeneca Plc:
* EUROPEAN MEDICINES AGENCY ACCEPTS REGULATORY SUBMISSION FOR FORXIGA IN ADULTS WITH TYPE-1 DIABETES
* SUBMISSION ACCEPTANCE IS BASED ON PHASE III DATA FROM DEPICT CLINICAL PROGRAMME FOR FORXIGA IN T1D Source text for Eikon: Further company coverage: